Silencing of ERK 2 with Small Interference RNA Regulates the Expression of CXCL1 in Th17 Cell

Patients with steroid-resistant asthma had their monocyte-derived TH17 cells collected. The expression levels of ERK2 in the TH17 were silenced and inhibited using ERK2 specific small interfering RNA (siRNA). By screening of CXCL1 and IL-17A in the TH17 culture supernatant, the expression levels of ERK2 and CXCL1 were determined. Using targeted siRNA to inhibit ERK2, the expression of ERK2 in the TH17 was reduced. Furthermore, inhibiting ERK2 hindered CXCL1 expression and decreased CXCL1 and IL-17A production. These findings suggest that ERK2 is involved in the synthesis of CXCL1 and IL-17A, two proteins that play a key role in the pathogenesis of hor-mone-resistant asthma.


Introduction
Asthma is a common chronic respiratory disease, and its global incidence is increasing year by year. The current treatment strategies include inhaled corticosteroids and β2 receptor agonists. The wide application of these treatments has effectively controlled the clinical symptoms of asthma patients and improved their quality of life. However, the mortality rate of asthma patients has not significantly decreased, indicating that there are still many unknown mechanisms for the pathogenesis and treatment of asthma [1] [2].
The current basic and clinical studies have found that the inflammatory cells of asthma airway are mainly eosinophilic infiltration, which respond well to hormone therapy. Inhaled or systemic glucocorticoids were also found to be effective and help control asthma symptoms. However, symptoms persist in about 5% -10% of asthma patients who have received adequate glucocorticoid therapy. These patients remain in a poorly controlled state and are affected by hormoneinsensitive or hormone-resistant asthma, subjecting the patient to greater physiological and psychological impact [3]. Airway infiltration with neutrophils as the primary inflammatory cells is the main pathophysiological basis of hormone-resistant asthma. This phenomenon is closely related to a new class of helper Tlymphocytes, namely, Th17 cells. Chemokine (CXC motif) ligand 1 (CXCL1) acts as a key chemoattractant for neutrophils in the pathogenesis of autoimmune diseases [4]. ERK2 is closely related to the occurrence of neutrophil inflammation [5]. However, the specific molecular machinery is not fully understood [6] [7]. Given this, this study aimed to explore the molecular mechanisms of adhesion molecule CXCL1 and the Raf-ERK signaling pathways in Th17 cell-mediated neutrophil airway infiltration, thereby deepening the understanding of hormone-resistant asthma.

Patients
10 patients from the Department of Respiratory and Critical Care Medicine of the First Affiliated Hospital of Xi'an Medical University between January 2017 and March 2018 who were diagnosed with steroid-resistant asthma were included in this investigation [8]. All procedures were performed in accordance with the Declaration of Helsinki for medical research involving human subjects, and written consent from the subjects was obtained. The ethics committee of the First Affiliated Hospital of Xi'an Medical University also approved the study procedures.

Isolation and Culture of TH17
Human peripheral blood mononuclear cells (PBMCs) were isolated from peripheral blood using Ficoll-Paque, as described previously [9]. Furthermore, the PBMCs were isolated from 5 mL of venous blood using Ficoll-Paque PLUS centrifuge, as described previously [10]. After centrifugation, the PBMCs were collected from the interphase layer and washed four times with RPMI-1640 Medium. Then, the PBMCs were gently re-suspended in 10 mL of RMPI-1640 Medium supplemented with 10% FCS and 10-mM EDTA. The PBMCs (1 × 10 7 cells/mL) suspended in RPMI-1640 Medium supplemented with 10% (v/v) FBS were incubated at 37˚C at 5% CO 2 in air with high humidity.

ERK2-Specific Silencing in Vitro
On day 7, the TH17 cells were harvested via flow cytometry (BD, Cat#560436) and ing of the expression of ERK2 in the TH17 cells were performed according to the methods described in a previous study [11].

RT-qPCR
Total RNA was isolated from the TH17 cells, which were collected 72 h after the

Western Blot
The TH17 cells were collected 72 h after the siRNA-ERK2 transfection. Total protein was extracted using ice-cold radioimmunoprecipitation lysis buffer (Santa Cruz, Biotechnology, Inc., Dallas, TX, USA). The protein concentrations were quantified using the Bradford method (Quick Start™; Bio-Rad, Hercules, CA, USA). Cytoplasmic protein samples (20 µg) were separated via 15% SDS-PAGE and semi-dry-transferred onto polyvinylidene difluoride membranes (EMD Millipore, Billerica, MA, USA). The membranes were blocked with 5% bovine serum albumin (Santa Cruz, Biotechnology, Inc.) for 1 h at room temperature. The blots were then incubated at 4˚C overnight with the following primary antibodies: anti-ERK2 (ab231085) and anti-GAPDH (ab8245 Abcam Biotechnology, Inc.) at a 1:1000 dilution in Tris-buffered saline with Tween-20 (TBST). GAPDH was used as a loading control. The blots were washed with TBST and then incubated with an anti-rabbit immunoglobulin G-horseradish peroxidase-conjugated secondary antibody (1:20,000 dilution in TBST; Pierce Biotechnology, Inc., Rockford, IL, USA) for 1 h at room temperature. After further washing with TBST, the blots were visualized using enhanced chemiluminescence (GE Healthcare Life Sciences, Little Chalfont, UK) and densitometrical quantified using a western blotting detection system (GE Healthcare Life Sciences). All results were normalized to GAPDH. Heat-induced epitope retrieval was conducted.

ELISA
The levels of inflammatory cytokines in the Th17 cell culture supernatants were analyzed via ELISA using ELISA kits for IL-17a and CXCL-1 (R&D Systems, Inc.) according to the manufacturer's protocols. A total of five mice were used for each group per experiment.

Statistical Analysis
Statistical analysis was conducted using the SPSS software version 20.0 (SPSS Inc., Chicago, IL, USA). Data were analyzed using T-Test, followed by LSD significant difference test. A value of P < 0.05 (two-tailed test) was considered statistically significant. The results are expressed as mean ± standard deviation unless otherwise stated.

ERK2-Specific siRNA Effectively Inhibits the Gene Expression of ERK2
To investigate whether ERK2-specific siRNA silenced the expression of ERK2 in the present study, the mRNA expression levels of ERK2 were detected via RT-qPCR.
The mRNA expression levels of ERK2 were downregulated in the ERK2-specific siRNA group 72 h after transfection compared with the control group (Figure 1(a) and Figure 1(b)). This indicated that ERK2-specific siRNA effectively inhibited the gene expression of ERK2.

ERK2-Specific siRNA Effectively Inhibited the Protein Expression Levels of ERK2
Western blot analysis revealed that the protein expression of ERK2 in the ERK2-siRNA group downregulated compared with the control and scrambled-siRNA group (Figure 2(a) and Figure 2(b)). These results indicated a signifi-Journal of Biosciences and Medicines cant reduction in the expression of ERK2 in the ERK2-siRNA group.

ERK2-siRNA Reduces the Gene Expression of CXCL1
To investigate whether ERK2-specific siRNA affected the gene expression levels of CXCL1, the mRNA levels of CXCL1 were detected via RT-qPCR. The mRNA expression levels of CXCL1 were downregulated in the ERK2-siRNA group 72 h after transfection compared with the control group ( Figure 3).   TH17 cells were collected 72 h post-transfection with ERK2 siRNA or phosphate-buffered saline vehicle. *P < 0.05, vs. control group. The experiment was performed three times and representa-tive results are presented. ERK2, extracellular regulated protein kinases 2; TH17, T helper 17 cell; siRNA, small interfering RNA; SD, standard deviation.

ERK2-siRNA Reduces the Protein Expression of CXCL1
The protein levels of CXCL1 were detected via western blot analysis and were downregulated in the ERK2-siRNA group compared with the control group. A significant difference was observed in the expression levels of CXCL1 between the ERK2-siRNA group and the control group ( Figure 4).

ERK2-siRNA Regulates the Production of Cytokines
The concentration of IL-17A and CXCL1 in the culture supernatants of the TH17 cells significantly decreased in the ERK2-siRNA group compared with the control and scrambled-siRNA group ( Figure 5).

Discussion
Since hormone-resistant asthma poses a significant challenge to clinical treatment. It is important to elucidate the pathogenesis of hormone-resistant asthma.
In the present study, specific siRNA was used to silence the expression of ERK2.
ERK2 silencing was found to downregulate the expression of CXCL1. This suggests that ERK2 is involved in the regulation of CXCL1 expression, which has  not been observed before. Numerous studies have been conducted to investigate the role of ERK2 during the development of asthma and have indicated that ERK2 is closely associated with the neutrophilic infiltration of the airways and the proliferation of airway smooth muscle cells [13] [14]. In addition, ERK2 mediates the production of CXCL8, indicating that ERK2 is closely related to the transcriptional regulation of the CXC family [15]. ERK2 can promote the expressions of CXCL1 and CXCL8, and then CXCL1 and CXCL8 can induce neutrophils to recruit airways. CXC chemokine(s) have been demonstrated to play an important role in recruiting neutrophils to inflamed tissues [16].
When the expression of ERK2 is inhibited by specific siRNA, which restrains the production of IL-17A, IL-17A can stimulate airway structural cells, including bronchial epithelial cells, to secrete CXCL8 and CXCL1 [17]. In the present in-vestigation, we employed specific siRNA silencing of ERK2, which downregulated the expression of CXCL1. In other words, ERK2 is closely involved in the expression and regulation of CXCL1. IL-17 is also another chemokine that attracts neutrophils. The IL-17 levels are elevated in the subjects with hormoneresistant asthma compared with those with controlled asthma or normal controls. Recent reports suggest that uncontrolled asthma is associated with elevated numbers of neutrophils and levels of neutrophil-attracting chemokines IL-8 and IL-17 in BAL fluids [18]. Subjects with asthma have greater percentages of IL-17A-positive PBMC compared with healthy control subjects [19] [20]. The number of bronchial IL-17F-positive cells correlates with the number of bronchial neutrophils and FEV1 (% predicted) [21]. Therefore, IL-17A and IL-17F are the central marker cytokines of TH17 cells, suggesting that the TH17 cells are closely related to hormone-resistant asthma.
Silencing the ERK2 expression via specific siRNA, and we found the production of IL-17A was correspondingly observed to decrease. IL-17 can promote the accumulation of neutrophils in the airways via Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) [22]. GM-CSF has the effect of prolonging the survival of neutrophils by inhibiting their apoptosis [23]. The IL-17-induced GM-CSF release is probably due to the inhibition of the transcription factor Nuclear Factor (NF)-κB [24]. The activation of NF-κB in the airway epithelial cells can produce chemokines that play an important role in neutrophil recruitment and inflammation in neutrophilic asthma [25]. MEK5DD and MEK1R4F synergize to activate an NF-κB-sensitive reporter. MEK5 and ERK5 are involved in the RafBXB activation of NF-κB. Moreover, ERK5 and ERK2 cooperate to regulate NF-κB [26]. Thus, we speculate that NF-κB/ERK2 mediates the infiltration of neutrophils in the airway induced by TH17 cells. Another study found that IL-17 and TNF-α promote the accumulation of neutrophils in the airways and have implications for human asthma and COPD [27]. ERK2, rather than ERK1, mediates LPS-induced GM-CSF expression in macrophages [28]. The NF-κB/ERK2 signaling pathway is involved in the regulation of neutrophil recruitment mediated by CXCL1, TNF-α, and GM-CSF, which together form a complex regulatory network.
In conclusion, this investigation demonstrated that ERK2 is important in the chemotaxis of neutrophils mediated by the TH17 cells. Inhibiting the expression of ERK2 with specific siRNA resulted in the downregulation of CXCL1 and reduced expression of IL-17A. These effects were associated with hormone-insensitive asthma mediated by neutrophils. However, CXCL1, TNF-α, and GM-CSF interact to induce neutrophil-based asthma, which still needs further investigation.